In March of 2016, at the age of 51, I was diagnosed with Younger Onset / Early-Stage Alzheimer’s Disease. You can read my full story here . Since my diagnosis, I have been working with great passion with the National Alzheimer’s Association as a member of the National Early-Stage Advisory Group (retired). I served on the board of directors for the Greater NJ chapter and as an Alzheimer’s Congressional Team member and NJ State Advocacy Champion (retired), and a Patient Advisor for Early Intervention Syste
Here is some of the advocacy and awareness work I’ve been doing to help with the fight to #ENDALZ. 2022 Jeff’s Story: Being Diagnosed with Alzheimer’s 2021 The Alzheimer’s economy: is the new $56,000-a-year drug worth it? New Alzheimer’s drug provides hope to South Jersey man FDA approves first drug intended to slow cognitive decline caused by Alzheimer’s disease CBS Evening News With Norah O’Donnell The FDA has approved a new – but controversial – drug that can treat Alzheimer’s. Biogen’s FDA Victo
Join The Fight